Fetal Chondrodysplasia Punctata: A Clinical Study of Five Cases

Qian Deng, Wen Wang, Meili Wang, Yanmei Wu, Yuanyuan Jin, Xiaoshu Zhou, Yaping Lu, Xiaohu WangResearch Square 2024 · DOI

TL;DR

This clinical study of five cases demonstrates that combining prenatal ultrasound with Whole Exome Sequencing (WES) is essential for the accurate diagnosis and subtyping of Fetal Chondrodysplasia Punctata (CDP). While ultrasound can identify the "stippling" of long bones, genetic testing is required to distinguish between lethal and manageable forms of the disorder, directly impacting prenatal counseling and pregnancy outcomes.

What Problem Does This Paper Address?

Chondrodysplasia punctata (CDP) is a rare group of bone dysplasias (occurring in roughly 1 in 100,000 live births) characterized by irregular, spot-like calcifications in the cartilage, known as "stippling."

The challenge for clinicians is that CDP is highly heterogeneous; it can be caused by genetic mutations, maternal autoimmune diseases, or even prenatal exposure to certain drugs (like warfarin). Because the prognosis ranges from neonatal lethality to a relatively normal life expectancy depending on the specific subtype, prenatal diagnosis is fraught with uncertainty. Most existing literature consists of isolated case reports, leaving a gap in standardized diagnostic protocols. This paper aims to improve prenatal diagnosis by correlating specific ultrasound markers with advanced genetic findings.

Methods

The researchers conducted a retrospective analysis of five fetuses from three families diagnosed with CDP at a specialized hospital between 2021 and 2023. Their diagnostic pipeline included:

  • Prenatal Ultrasound: Specifically looking for punctate echogenicity (strong, spot-like echoes) in the long bones, spine, and facial structures (to identify Binder syndrome or cataracts).
  • Standard Genetic Testing: Chromosome karyotyping and Chromosomal Microarray Analysis (CMA) were performed first.
  • Advanced Genetic Testing: When standard tests returned normal results, the team employed Whole Exome Sequencing (WES) to identify regional pathogenic gene variations.
  • Clinical Correlation: Postnatal imaging (X-rays) and follow-up were used to confirm prenatal findings.

Datasets

As a clinical case study, the "dataset" consists of the medical records, ultrasound imagery, and genetic profiles of five fetuses from three distinct families. No external large-scale benchmarks or public datasets were used, as the study focuses on primary clinical data.

Key Insights and Ideas

  • The "Smoking Gun" Marker: Punctate strong echogenicity at the ends of long bones (femur, tibia, humerus) was present in 100% of the cases, making it the primary red flag for CDP during a second-trimester scan.
  • Standard Tests are Insufficient: In all five cases, both karyotyping and CMA (the standard "first-tier" genetic tests) appeared normal. Only WES was able to pinpoint the underlying mutations, highlighting its necessity in skeletal dysplasia cases.
  • Genotype-Phenotype Correlation: The study successfully mapped specific genes to CDP subtypes:
  • PEX7 mutations led to Rhizomelic CDP (RCDP), characterized by severe limb shortening and a poor prognosis.
  • EBP mutations resulted in CDPX2 (X-linked dominant), often involving cataracts and asymmetric limb shortening.
  • ARSE mutations caused CDPX1 (X-linked recessive), which presented with milder symptoms like Binder syndrome (flat nose bridge) and a much more favorable prognosis.

Key Results

  • Ultrasound Findings: Beyond the 100% occurrence of stippling, 80% of fetuses had shortened long bones, 60% had spinal anomalies, and 40% presented with cataracts.
  • Genetic Success: WES identified pathogenic variations in every case:
  • Family 1: Compound heterozygous variations in the PEX7 gene.
  • Family 2: A new mutation in the EBP gene.
  • Family 3: A hemizygous variation in the ARSE gene.
  • Pregnancy Outcomes: Four out of five pregnancies were terminated due to the severity of the predicted subtype. The one fetus with the ARSE mutation (CDPX1) was carried to term. Despite initial respiratory distress at birth, the infant is growing well with a normal life expectancy, confirming the value of accurate subtyping for parental decision-making.

Limitations and Future Work

The primary limitation is the small sample size (n=5), which is expected given the rarity of the condition but limits broader statistical generalizations. Additionally, because four of the five cases resulted in the termination of pregnancy, long-term follow-up data for these specific genetic variations is limited.

The authors suggest that future research should focus on expanding the sample size through multi-center studies and incorporating even more comprehensive genetic screening to further map the spectrum of mutations that cause CDP. This would help refine the "prognostic map" clinicians use when advising expectant parents.

Summary updated

Abstract

<title>Abstract</title> Background To explore prenatal ultrasonic manifestations, genetic etiology and pregnancy outcomes of fetal chondrodysplasia punctata (CDP). Methods Five fetuses from three families diagnosed with CDP by prenatal ultrasound were retrospectively analysed, and the clinical features, genetic testing results and pregnancy outcomes of CDP cases were analysed. Results (1)Prenatal ultrasound showed punctate strong echogenicity of long diaphyseal epiphysis(mainly at femur,tibia,humerus) in all five fetuses. Four fetuses (4/5,80%) were complicated with short long bones. Three fetuses (3/5,60%) were complicated with spinal anomalies and one case(1/5,20%) were complicated with Binder syndrome. Cataracts were presented in 2 fetuses(2/5,40%). (2) Genetic testing was performed in all five fetuses. There were no abnormalities in chromosome karyotype and chromosomal microarray analysis(CMA). However some regional gene pathogenic variations were found in whole exome sequencing(WES). (3)Induced labour was performed in four fetuses. Only one fetus was delivered at 39 weeks of gestation and transferred to the department of pediatrics for respiratory support due to dyspnea after birth, and had the good prognosis with follow-up. Conclusion The fetuses diagnosed with CDP mostly have genetic abnormalities and adverse neonatal outcomes. For fetuses with punctate strong echogenicity of long diaphyseal epiphysis and short long bones detected by ultrasound, it is necessary to comprehensively screen for other systemic malformations, especially spinal dysplasia and facial malformations. Genetic testing is recommended.
BibTeX
@inproceedings{deng2024fetal,
  author = {Qian Deng and Wen Wang and Meili Wang and Yanmei Wu and Yuanyuan Jin and Xiaoshu Zhou and Yaping Lu and Xiaohu Wang},
  title = {{Fetal Chondrodysplasia Punctata: A Clinical Study of Five Cases}},
  booktitle = {Research Square},
  year = {2024},
  doi = {10.21203/rs.3.rs-4970975/v1},
}
Figure